Allergy and Intolerance Information
Allergy and Intolerance Information
Allergy and Intolerance InformationAllergy AdvisorAllergy Resources International
Allergy and Intolerance InformationAllAllergy.net
Allergy and Intolerance Information
Allergy and Intolerance Information
Allergy and Intolerance Information
Index Allergens and Substances List Allergy Advisor Digest Contents of Journals Allergen and Substance Search
 Allergy: Journal Articles Listed in February 2015
Phadia   Easy reference to all new journal articles added last month - Our complete list of titles Allergy Articles, Allergy Journals
Journal List    ALL Journals by Month Allergy Articles, Allergy Journals
Want to subscribe to our reminder service?   Tell a Friend!   Search Allergy Articles, Allergy Journals
   Allergy      *General      Dietetic      Food      **Allergen
* General: General Allergy articles from Dietetic & Food journals
** Allergen: Food allergy, Allergens & Intolerance articles from all journals
Allergy Articles, Allergy Journals
Previous Months
May 2012   June 2012   July 2012   August 2012   September 2012   October 2012   November 2012   December 2012   January 2013   February 2013   March 2013   April 2013   May 2013   June 2013   July 2013   August 2013   September 2013   October 2013   November 2013   December 2013   January 2014   February 2014   March 2014   April 2014   May 2014   June 2014   July 2014   August 2014   September 2014   October 2014   November 2014   December 2014   January 2015   February 2015   All Allergy Articles, Allergy Journals
  Articles: 537

1
Pediatric allergy.   
Immunol Allergy Clin North Am 2015 Feb;35(1):xiii-xxiv   abstract
_______________________________________________________________

2
Drug and vaccine allergy.   
Immunol Allergy Clin North Am 2015 Feb;35(1):221-230   abstract
_______________________________________________________________

3
Anaphylaxis and urticaria.   
Immunol Allergy Clin North Am 2015 Feb;35(1):199-219   abstract
_______________________________________________________________

4
Pediatric allergic rhinitis.   
Immunol Allergy Clin North Am 2015 Feb;35(1):185-198   abstract
_______________________________________________________________

5
Atopic dermatitis in children: clinical features, pathophysiology, and treatment.   
Immunol Allergy Clin North Am 2015 Feb;35(1):161-183   abstract
_______________________________________________________________

6
Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.   
Immunol Allergy Clin North Am 2015 Feb;35(1):129-144   abstract
_______________________________________________________________

7
Asthma: the interplay between viral infections and allergic diseases.   
Immunol Allergy Clin North Am 2015 Feb;35(1):115-127   abstract
_______________________________________________________________

8
Inner city asthma.   
Immunol Allergy Clin North Am 2015 Feb;35(1):101-114   abstract
_______________________________________________________________

9
Potential treatments for food allergy.   
Immunol Allergy Clin North Am 2015 Feb;35(1):77-100   abstract
_______________________________________________________________

10
Optimizing the diagnosis of food allergy.   
Immunol Allergy Clin North Am 2015 Feb;35(1):61-76   abstract
_______________________________________________________________

11
Food allergy: epidemiology and natural history.   
Immunol Allergy Clin North Am 2015 Feb;35(1):45-59   abstract
_______________________________________________________________

12
Genetics of allergic diseases.   
Immunol Allergy Clin North Am 2015 Feb;35(1):19-44   abstract
_______________________________________________________________

13
The role of the early-life environment in the development of allergic disease.   
Immunol Allergy Clin North Am 2015 Feb;35(1):1-17   abstract
_______________________________________________________________

14
Ige sensitization to Thaumetopoea pityocampa : diagnostic utility of a setae extract, clinical picture and associated risk factors.   
Int Arch Allergy Immunol 2014;165(4):283-290   abstract
_______________________________________________________________

15
Immunological aspects of the immune response induced by mosquito allergens.   
Int Arch Allergy Immunol 2014;165(4):271-282   abstract
_______________________________________________________________

16
In memoriam - a tribute to Carlos E. Baena-Cagnani.   
Int Arch Allergy Immunol 2014;165(4):270   abstract
_______________________________________________________________

17
Coexistence of angioedema alone with impaired glucose tolerance.   
Int Arch Allergy Immunol 2014;165(4):265-269   abstract
_______________________________________________________________

18
Inhibition of Allergen-Induced Basophil Activation by ASM-024, a Nicotinic Receptor Ligand.   
Int Arch Allergy Immunol 2014;165(4):255-264   abstract
_______________________________________________________________

19
Effects of Oral Administration of Lactobacillus acidophilus L-92 on the Symptoms and Serum Cytokines of Atopic Dermatitis in Japanese Adults: A Double-Blind, Randomized, Clinical Trial.   
Int Arch Allergy Immunol 2014;165(4):247-254   abstract
_______________________________________________________________

20
Characteristics of 26 kDa antigen of H. Pylori by Monoclonal Antibody.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):113-119   abstract
_______________________________________________________________

21
Development of a new immunochromatographic assay using gold nanoparticles for screening of IgA deficiency.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):105-112   abstract
_______________________________________________________________

22
Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):98-104   abstract
_______________________________________________________________

23
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):91-97   abstract
_______________________________________________________________

24
Impact and correlation of environmental conditions on pollen counts in karachi, pakistan.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):83-90   abstract
_______________________________________________________________

25
Immunochemical characterization of prosopis juliflora pollen allergens and evaluation of cross-reactivity pattern with the most allergenic pollens in tropical areas.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):74-82   abstract
_______________________________________________________________

26
Cotinine level is associated with asthma severity in passive smoker children.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):67-73   abstract
_______________________________________________________________

27
Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):60-66   abstract
_______________________________________________________________

28
Association between Interleukin-1 Receptor Antagonist (IL1RN) Variable Number of Tandem Repeats (VNTR) Polymorphism and Pulmonary Tuberculosis.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):55-59   abstract
_______________________________________________________________

29
Lack of Association between Toll Like Receptor-2 and Toll Like Receptor-4 Gene Polymorphisms and Other Feature in Iranian Asthmatics Patients.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):48-54   abstract
_______________________________________________________________

30
Emotional Freedom Technique (EFT) Effects on Psychoimmunological Factors of Chemically Pulmonary Injured Veterans.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):37-47   abstract
_______________________________________________________________

31
Clinical and immunological effects of a forest trip in children with asthma and atopic dermatitis.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):28-36   abstract
_______________________________________________________________

32
Odor-related Chronic Somatic Symptoms Are Associated with Self-Reported Asthma and Hay Fever: The Hordaland Health Study.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):19-27   abstract
_______________________________________________________________

33
Flow cytometry applications in the study of immunological lung disorders.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):12-18   abstract
_______________________________________________________________

34
Association between FcepsilonRIbeta and IFN-gamma Polymorphisms and Asthma in Asian Population: a Meta-Analysis.   
Iran J Allergy Asthma Immunol 2015 Feb;14(1):1-11   abstract
_______________________________________________________________

35
Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: a report of two cases.   
J Allergy Clin Immunol Pract 2015 Feb 13;   abstract
_______________________________________________________________

36
Incidence of suspected perioperative anaphylaxis-a multicenter snapshot study.   
J Allergy Clin Immunol Pract 2015 Feb 13;   abstract
_______________________________________________________________

37
Absence of peripheral eosinophilia on initial clinical presentation does not rule out the diagnosis of acute eosinophilic pneumonia.   
J Allergy Clin Immunol Pract 2015 Feb 12;   abstract
_______________________________________________________________

38
Investigation of patient-specific characteristics associated with treatment outcomes for chronic urticaria.   
J Allergy Clin Immunol Pract 2015 Feb 10;   abstract
_______________________________________________________________

39
Recombinant Human-C1 Inhibitor is Effective and Safe for Repeat Hereditary Angioedema Attacks.   
J Allergy Clin Immunol Pract 2015 Feb 10;   abstract
_______________________________________________________________

40
Meropenem tolerance in a patient with probable fulminant piperacillin-induced immune hemolytic anemia.   
J Allergy Clin Immunol Pract 2015 Feb 10;   abstract
_______________________________________________________________

41
Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis.   
J Allergy Clin Immunol Pract 2015 Feb 11;   abstract
_______________________________________________________________

42
Omalizumab in the treatment of aspirin-exacerbated respiratory disease.   
J Allergy Clin Immunol Pract 2015 Jan 30;   abstract
_______________________________________________________________

43
beta-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system.   
J Allergy Clin Immunol 2015 Feb 19;   abstract
_______________________________________________________________

44
Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both.   
J Allergy Clin Immunol 2015 Feb 19;   abstract
_______________________________________________________________

45
Safety of live attenuated influenza vaccine in atopic children with egg allergy.   
J Allergy Clin Immunol 2015 Feb 1;   abstract
_______________________________________________________________

46
Prevention of allergic asthma through Der p 2 peptide vaccination.   
J Allergy Clin Immunol 2015 Feb 11;   abstract
_______________________________________________________________

47
Intracellular residency of Staphylococcus aureus within mast cells in nasal polyps: A novel observation.   
J Allergy Clin Immunol 2015 Feb 11;   abstract
_______________________________________________________________

48
Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis.   
J Allergy Clin Immunol 2015 Feb 11;   abstract
_______________________________________________________________

49
Blood DNA methylation biomarkers predict clinical reactivity in food-sensitized infants.   
J Allergy Clin Immunol 2015 Feb 10;   abstract
_______________________________________________________________

50
Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.   
J Allergy Clin Immunol 2015 Feb 10;   abstract
_______________________________________________________________

51
A novel mutation in ICOS presenting as hypogammaglobulinemia with susceptibility to opportunistic pathogens.   
J Allergy Clin Immunol 2015 Feb 10;   abstract
_______________________________________________________________

52
Sex-related differences in pulmonary physiologic outcome measures in a high-risk birth cohort.   
J Allergy Clin Immunol 2015 Feb 9;   abstract
_______________________________________________________________

53
Filaggrin gene mutations are not associated with food and aeroallergen sensitization without concomitant atopic dermatitis in adults.   
J Allergy Clin Immunol 2015 Feb 10;   abstract
_______________________________________________________________

54
Rare variants at 16p11.2 are associated with common variable immunodeficiency.   
J Allergy Clin Immunol 2015 Feb 10;   abstract
_______________________________________________________________

55
IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.   
J Allergy Clin Immunol 2015 Jan 27;   abstract
_______________________________________________________________

56
Risk of an asthma exacerbation after bariatric surgery in adults.   
J Allergy Clin Immunol 2015 Feb 7;   abstract
_______________________________________________________________

57
IgG inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens.   
J Allergy Clin Immunol 2015 Feb 7;   abstract
_______________________________________________________________

58
Correlation of sensitizing capacity and T-cell recognition within the Bet v 1 family.   
J Allergy Clin Immunol 2015 Feb 7;   abstract
_______________________________________________________________

59
Prevention of atopic dermatitis by moisturizer in neonates.   
J Allergy Clin Immunol 2015 Feb 7;   abstract
_______________________________________________________________

60
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation.   
J Allergy Clin Immunol 2015 Feb;135(2):551-553   abstract
_______________________________________________________________

61
Studies of house dust mites can now fully embrace the '-omics' era.   
J Allergy Clin Immunol 2015 Feb;135(2):549-550   abstract
_______________________________________________________________

62
Eosinophils and itch: Partners in crime or strange bedfellows?   
J Allergy Clin Immunol 2015 Feb;135(2):488-490   abstract
_______________________________________________________________

63
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2014.   
J Allergy Clin Immunol 2015 Feb;135(2):357-367   abstract
_______________________________________________________________

64
Targeted therapy for allergic diseases: At the intersection of cutting-edge science and clinical practice.   
J Allergy Clin Immunol 2015 Feb;135(2):354-356   abstract
_______________________________________________________________

65
The future of biologics: Applications for food allergy.   
J Allergy Clin Immunol 2015 Feb;135(2):312-323   abstract
_______________________________________________________________

66
Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care.   
J Allergy Clin Immunol 2015 Feb;135(2):299-310   abstract
_______________________________________________________________

67
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.   
J Allergy Clin Immunol 2015 Feb 3;   abstract
_______________________________________________________________

68
Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma.   
J Allergy Clin Immunol 2015 Feb 3;   abstract
_______________________________________________________________

69
Culture medium from TNF-alpha-stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms.   
J Allergy Clin Immunol 2015 Feb 1;   abstract
_______________________________________________________________

70
The long-term programming effect of maternal 25-hydroxyvitamin D in pregnancy on allergic airway disease and lung function in offspring after 20 to 25 years of follow-up.   
J Allergy Clin Immunol 2015 Jan 30;   abstract
_______________________________________________________________

71
Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus.   
J Allergy Clin Immunol 2015 Jan 30;   abstract
_______________________________________________________________

72
The polyamine spermine promotes survival and activation of human eosinophils.   
J Allergy Clin Immunol 2015 Jan 30;   abstract
_______________________________________________________________

73
Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergist.   
J Allergy Clin Immunol 2015 Jan 30;   abstract
_______________________________________________________________

74
Advances in pediatric asthma in 2014: Moving toward a population health perspective.   
J Allergy Clin Immunol 2015 Jan 30;   abstract
_______________________________________________________________

75
Clinical relevance of the Hevea brasiliensis lipid transfer protein Hev b 12.   
J Allergy Clin Immunol 2015 Jan 30;   abstract
_______________________________________________________________

76
Prime role of IL-17A in neutrophilia and airway smooth muscle contraction in a house dust mite-induced allergic asthma model.   
J Allergy Clin Immunol 2015 Jan 30;   abstract
_______________________________________________________________

77
A functional brain-derived neurotrophic factor (BDNF) gene variant increases the risk of moderate-to-severe allergic rhinitis.   
J Allergy Clin Immunol 2015 Jan 30;   abstract
_______________________________________________________________

78
The draft genome, transcriptome, and microbiome of Dermatophagoides farinae reveal a broad spectrum of dust mite allergens.   
J Allergy Clin Immunol 2015 Feb;135(2):539-548   abstract
_______________________________________________________________

79
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice.   
J Allergy Clin Immunol 2015 Feb;135(2):528-538   abstract
_______________________________________________________________

80
Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy.   
J Allergy Clin Immunol 2015 Feb;135(2):370-378   abstract
_______________________________________________________________

81
Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children.   
J Allergy Clin Immunol 2015 Feb;135(2):441-448   abstract
_______________________________________________________________

82
DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4(+) T-cell function without causing severe combined immunodeficiency.   
J Allergy Clin Immunol 2015 Feb;135(2):425-440   abstract
_______________________________________________________________

83
The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy.   
J Allergy Clin Immunol 2015 Feb;135(2):407-412   abstract
_______________________________________________________________

84
Effect of ingested H1 antihistamines on methacholine challenge.   
J Allergy Clin Immunol 2015 Feb;135(2):579-580   abstract
_______________________________________________________________

85
Ramipril and metoprolol intake aggravate human and murine anaphylaxis: Evidence for direct mast cell priming.   
J Allergy Clin Immunol 2015 Feb;135(2):491-499   abstract
_______________________________________________________________

86
Changes in peanut allergy prevalence in different ethnic groups in 2 time periods.   
J Allergy Clin Immunol 2015 Feb;135(2):580-582   abstract
_______________________________________________________________

87
Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease.   
J Allergy Clin Immunol 2015 Feb;135(2):413-424   abstract
_______________________________________________________________

88
Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States.   
J Allergy Clin Immunol 2015 Feb;135(2):463-469   abstract
_______________________________________________________________

89
Associations between the 17q21 region and allergic rhinitis in 5 birth cohorts.   
J Allergy Clin Immunol 2015 Feb;135(2):573-576   abstract
_______________________________________________________________

90
Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor.   
J Allergy Clin Immunol 2015 Feb;135(2):567-570   abstract
_______________________________________________________________

91
Hereditary angioedema: Molecular and clinical differences among European populations.   
J Allergy Clin Immunol 2015 Feb;135(2):570-573   abstract
_______________________________________________________________

92
Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease.   
J Allergy Clin Immunol 2015 Feb;135(2):508-516   abstract
_______________________________________________________________

93
The coreceptor programmed death 1 inhibits T-cell adhesion by regulating Rap1.   
J Allergy Clin Immunol 2015 Feb;135(2):564-567   abstract
_______________________________________________________________

94
Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome.   
J Allergy Clin Immunol 2015 Feb;135(2):561-564   abstract
_______________________________________________________________

95
Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.   
J Allergy Clin Immunol 2015 Feb;135(2):500-507   abstract
_______________________________________________________________

96
IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers.   
J Allergy Clin Immunol 2015 Feb;135(2):379-385   abstract
_______________________________________________________________

97
Humanized anti-IFN-gamma (HuZAF) in the treatment of psoriasis.   
J Allergy Clin Immunol 2015 Feb;135(2):553-556   abstract
_______________________________________________________________

98
Maximal flow at functional residual capacity in asthmatic preschool children.   
J Asthma 2015 Feb 24;1-5   abstract
_______________________________________________________________

99
Use of subcutaneous-C1 INH for acute therapy and prophylaxis of a child with HAE.   
Pediatr Allergy Immunol 2015 Feb 23;   abstract
_______________________________________________________________

100
Sleep in children with atopic dermatitis.   
Pediatr Allergy Immunol 2015 Feb 23;   abstract
_______________________________________________________________

101
Non-adherence in children with asthma reviewed: the need for improvement of asthma care and medical education.   
Pediatr Allergy Immunol 2015 Feb 23;   abstract
_______________________________________________________________

102
What lessons can be learned about asthma phenotypes in children from cohort studies?   
Pediatr Allergy Immunol 2015 Feb 21;   abstract
_______________________________________________________________

103
Design and validation of pictograms in a pediatric anaphylaxis action plan.   
Pediatr Allergy Immunol 2015 Feb 20;   abstract
_______________________________________________________________

104
Food consumption and risk of childhood asthma.   
Pediatr Allergy Immunol 2015 Feb 18;   abstract
_______________________________________________________________

105
Long-lasting non-IgE-mediated gastrointestinal cow's milk allergy in infants with Down syndrome.   
Pediatr Allergy Immunol 2015 Feb 18;   abstract
_______________________________________________________________

106
Vernal Keratoconjunctivitis and immune mediated diseases: one unique way to symptom control?   
Pediatr Allergy Immunol 2015 Feb 18;   abstract
_______________________________________________________________

107
Impact of oral immunotherapy on quality of life in egg allergic children.   
Pediatr Allergy Immunol 2015 Feb 18;   abstract
_______________________________________________________________

108
Immunomodulating properties of protein hydrolysates for application in cow's milk allergy.   
Pediatr Allergy Immunol 2015 Feb 18;   abstract
_______________________________________________________________

109
Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-year-old girl.   
Pediatr Allergy Immunol 2015 Feb 18;   abstract
_______________________________________________________________

110
Intestinal lymphoid nodular hyperplasia in children: The relationship to food allergy.   
Pediatr Allergy Immunol 2015 Feb;26(1):18-24   abstract
_______________________________________________________________

111
Maternal Preeclampsia and Childhood Asthma in the Offspring.   
Pediatr Allergy Immunol 2015 Jan 30;   abstract
_______________________________________________________________

112
Improved management of childhood atopic dermatitis after individually tailored nurse consultations: A pilot study.   
Pediatr Allergy Immunol 2015 Jan 23;   abstract
_______________________________________________________________

113
Childhood Asthma is Associated with Polymorphic Markers of PROC on 2q14 in Addition to 17q21 Locus.   
Pediatr Allergy Immunol 2015 Jan 19;   abstract
_______________________________________________________________

114
Non-allergenic factors from pollen modulate T helper cell instructing notch ligands on dendritic cells   
WAO Journal 2015;8:2-   abstract
_______________________________________________________________

115
World Allergy Organization – McMaster University guidelines for allergic disease prevention (GLAD-P): Probiotics   
WAO Journal 2015;8:4-   abstract
_______________________________________________________________

116
The care pathway for children with urticaria, angioedema, mastocytosis   
WAO Journal 2015;8:5-   abstract
_______________________________________________________________

117
The microbiome of the upper airways: focus on chronic rhinosinusitis   
WAO Journal 2015;8:3-   abstract
_______________________________________________________________

118
Contact allergy induced by bisphenol A diglycidyl ether leachables from aluminium tubes for pharmaceutical use.   
Allergy 2015 Feb;70(2):220-226   abstract
_______________________________________________________________

119
Damage-associated molecular pattern and innate cytokine release in the airways of competitive swimmers.   
Allergy 2015 Feb;70(2):187-194   abstract
_______________________________________________________________

120
Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria.   
Allergy 2015 Feb;70(2):153-160   abstract
_______________________________________________________________

121
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials.   
Allergy 2015 Feb 20;   abstract
_______________________________________________________________

122
Serum periostin levels correlate with airway hyperresponsiveness to methacholine and mannitol in children with asthma.   
Allergy 2015 Feb 20;   abstract
_______________________________________________________________

123
Asthma phenotypes and lung function up to 16 years of age - the BAMSE cohort.   
Allergy 2015 Feb 20;   abstract
_______________________________________________________________

124
Factors that predict in-hospital mortality in eosinophilic granulomatosis with polyangiitis.   
Allergy 2015 Feb 20;   abstract
_______________________________________________________________

125
The circadian clock functions as a potent regulator of allergic reaction.   
Allergy 2015 Feb 17;   abstract
_______________________________________________________________

126
IL-33 drives airway hyper-responsiveness through IL-13 mediated mast cell:airway smooth muscle crosstalk.   
Allergy 2015 Feb 12;   abstract
_______________________________________________________________

127
Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE.   
Allergy 2015 Feb 13;   abstract
_______________________________________________________________

128
Excess subcutaneous tissue may preclude intramuscular delivery when using epinephrine autoinjectors in patients with anaphylaxis.   
Allergy 2015 Feb 13;   abstract
_______________________________________________________________

129
IL-33 promotes the induction of immunoglobulin production after inhalation of HDM in mice.   
Allergy 2015 Feb 12;   abstract
_______________________________________________________________

130
Interleukin-33 exacerbates allergic bronchoconstriction in the mice via activation of mast cells.   
Allergy 2015 Feb 7;   abstract
_______________________________________________________________

131
Detection of relevant amounts of cow's milk protein in non-pre-packed bakery products sold as cow's milk free.   
Allergy 2015 Feb 4;   abstract
_______________________________________________________________

132
Skin tests in patients with hypersensitivity reaction to iodinated contrast media: A meta-analysis.   
Allergy 2015 Feb 3;   abstract
_______________________________________________________________

133
Comprehensive metabolomics identifies the alarmin uric acid as a critical signal for the induction of peanut allergy.   
Allergy 2015 Feb 3;   abstract
_______________________________________________________________

134
Insights and advances in chronic urticaria: a Canadian perspective.   
Allergy Asthma Clin Immunol 2015;11(1):7   abstract
_______________________________________________________________

135
Reviewer acknowledgement 2014.   
Allergy Asthma Clin Immunol 2015;11(1):6   abstract
_______________________________________________________________

136
Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU).   
Allergy Asthma Clin Immunol 2015;11(1):5   abstract
_______________________________________________________________

137
Removal of peanut allergen Ara h 1 from common hospital surfaces, toys and books using standard cleaning methods.   
Allergy Asthma Clin Immunol 2015;11(1):4   abstract
_______________________________________________________________

138
Lung function, airway remodeling, and inflammation in infants: outcome at 8 years.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):90-96   abstract
_______________________________________________________________

139
Epinephrine doses contained in outdated epinephrine auto-injectors collected in a Florida allergy practice.   
Ann Allergy Asthma Immunol 2015 Feb 20;   abstract
_______________________________________________________________

140
Critical appraisal of androgen use in hereditary angioedema: A systematic review.   
Ann Allergy Asthma Immunol 2015 Feb 20;   abstract
_______________________________________________________________

141
Expanding the spectrum: chronic urticaria and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.   
Ann Allergy Asthma Immunol 2015 Feb 20;   abstract
_______________________________________________________________

142
Chronic lymphocytic lymphoma presenting with recurrent demodicidosis.   
Ann Allergy Asthma Immunol 2015 Feb 20;   abstract
_______________________________________________________________

143
X-linked agammaglobulinemia in a child conceived using a donor egg: a medicolegal quandary.   
Ann Allergy Asthma Immunol 2015 Feb 19;   abstract
_______________________________________________________________

144
The mamey sapote fruit (Pouteria sapota) as a novel cause of IgE-mediated allergic reaction.   
Ann Allergy Asthma Immunol 2015 Feb 19;   abstract
_______________________________________________________________

145
Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis.   
Ann Allergy Asthma Immunol 2015 Feb 19;   abstract
_______________________________________________________________

146
Immune profile modulation of blood and mucosal eosinophils in nasal polyposis with concomitant asthma.   
Ann Allergy Asthma Immunol 2015 Feb 19;   abstract
_______________________________________________________________

147
Dynamics of house dust mite transfer in modern clothing fabrics.   
Ann Allergy Asthma Immunol 2015 Feb 10;   abstract
_______________________________________________________________

148
Clinical and cytokine responses to house dust mite sublingual immunotherapy.   
Ann Allergy Asthma Immunol 2015 Feb 3;   abstract
_______________________________________________________________

149
Design of a smartphone application to monitor stress, asthma symptoms, and asthma inhaler use.   
Ann Allergy Asthma Immunol 2015 Feb 3;   abstract
_______________________________________________________________

150
Integrative medicine is integral to providing patient-centered care.   
Ann Allergy Asthma Immunol 2015 Feb 3;   abstract
_______________________________________________________________

151
Phenotyping allergic rhinitis as early- or dual-phase responses using the environmental exposure unit.   
Ann Allergy Asthma Immunol 2015 Feb 3;   abstract
_______________________________________________________________

152
Treatment of allergic reactions and quality of life among caregivers of food-allergic children.   
Ann Allergy Asthma Immunol 2015 Feb 5;   abstract
_______________________________________________________________

153
Allergen of the month-sandbar willow.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):A21   abstract
_______________________________________________________________

154
Syncope as a manifestation of mast cell activation disorder.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):153-154   abstract
_______________________________________________________________

155
Efficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):141-147   abstract
_______________________________________________________________

156
SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):134-140   abstract
_______________________________________________________________

157
Elevated exhaled leukotriene B4 in the small airway compartment in children with asthma.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):111-116   abstract
_______________________________________________________________

158
Sinus and adenoid inflammation in children with chronic rhinosinusitis and asthma.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):103-110   abstract
_______________________________________________________________

159
Mold allergy revisited.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):83-89   abstract
_______________________________________________________________

160
A curious case of cough.   
Ann Allergy Asthma Immunol 2015 Feb;114(2):80-82   abstract
_______________________________________________________________

161
Do all asthmatic patients have the same disease?   
Ann Allergy Asthma Immunol 2015 Feb;114(2):78-79   abstract
_______________________________________________________________

162
Anaphylaxis due to caffeine.   
Asia Pac Allergy 2015 Jan;5(1):55-56   abstract
_______________________________________________________________

163
Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation.   
Asia Pac Allergy 2015 Jan;5(1):51-54   abstract
_______________________________________________________________

164
Refractory intraoperative hypotension with elevated serum tryptase.   
Asia Pac Allergy 2015 Jan;5(1):47-50   abstract
_______________________________________________________________

165
Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity.   
Asia Pac Allergy 2015 Jan;5(1):40-46   abstract
_______________________________________________________________

166
Reduced severity and improved control of self-reported asthma in Finland during 2001-2010.   
Asia Pac Allergy 2015 Jan;5(1):32-39   abstract
_______________________________________________________________

167
Validation of the Korean version of the European Community Respiratory Health Survey screening questionnaire for use in epidemiologic studies for adult asthma.   
Asia Pac Allergy 2015 Jan;5(1):25-31   abstract
_______________________________________________________________

168
Carbohydrates as food allergens.   
Asia Pac Allergy 2015 Jan;5(1):17-24   abstract
_______________________________________________________________

169
Tick-induced allergies: mammalian meat allergy, tick anaphylaxis and their significance.   
Asia Pac Allergy 2015 Jan;5(1):3-16   abstract
_______________________________________________________________

170
Asia Pacific allergy: four years of experience.   
Asia Pac Allergy 2015 Jan;5(1):1-2   abstract
_______________________________________________________________

171
Staphylococcus aureus and primary lysis of eosinophils.   
Clin Exp Allergy 2015 Feb;45(2):488-489   abstract
_______________________________________________________________

172
Author response to 'Staphylococcus aureus and primary lysis of eosinophils' by Dr Persson.   
Clin Exp Allergy 2015 Feb;45(2):490-491   abstract
_______________________________________________________________

173
Oral immunotherapy for food allergy: mechanisms and role in management.   
Clin Exp Allergy 2015 Feb;45(2):368-383   abstract
_______________________________________________________________

174
Frequency, severity and causes of unexpected allergic reactions to food: a systematic literature review.   
Clin Exp Allergy 2015 Feb;45(2):347-367   abstract
_______________________________________________________________

175
Allergic disorders and socioeconomic status: a study of school children in an urban area of Makassar, Indonesia.   
Clin Exp Allergy 2015 Feb 21;   abstract
_______________________________________________________________

176
Plasma IL-33 in atopic patients correlates with pro-inflammatory cytokines and changes cholesterol transport protein expression: a surprising neutral overall impact on atherogenicity.   
Clin Exp Allergy 2015 Feb 21;   abstract
_______________________________________________________________

177
Raised immunoglobulin A and circulating T follicular helper cells are linked to the development of food allergy in pediatric liver transplant patients.   
Clin Exp Allergy 2015 Feb 20;   abstract
_______________________________________________________________

178
IgE responses to Ascaris and mite tropomyosins are risk factors for asthma.   
Clin Exp Allergy 2015 Feb 19;   abstract
_______________________________________________________________

179
Prediction of childhood atopy by questionnaire.   
Clin Exp Allergy 2015 Feb 12;   abstract
_______________________________________________________________

180
Nasal lavage is better than blood count in predicting sputum eosinophilia.   
Clin Exp Allergy 2015 Feb 13;   abstract
_______________________________________________________________

181
Non-pharmacological interventions aimed at modifying health and behavioural outcomes for adults with asthma: a critical review.   
Clin Exp Allergy 2015 Feb 12;   abstract
_______________________________________________________________

182
Differential TLR-induced cytokine production by human mast cells is amplified by FcvarepsilonRI triggering.   
Clin Exp Allergy 2015 Feb 9;   abstract
_______________________________________________________________

183
Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes.   
Clin Exp Allergy 2015 Feb 5;   abstract
_______________________________________________________________

184
Defintion of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergens.   
Clin Exp Allergy 2015 Feb 5;   abstract
_______________________________________________________________

185
Mechanisms of airway hyperresponsiveness in asthma: the past, present and yet to come.   
Clin Exp Allergy 2015 Feb 4;   abstract
_______________________________________________________________

186
Effects of short term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma- a randomised controlled trial.   
Clin Exp Allergy 2015 Feb 1;   abstract
_______________________________________________________________

187
Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic esophagitis.   
Clin Exp Allergy 2015 Feb 1;   abstract
_______________________________________________________________

188
Lower anti-echovirus antibody responses in children presenting to hospital with asthma exacerbations.   
Clin Exp Allergy 2015 Feb 1;   abstract
_______________________________________________________________

189
What goes up must come down: biomarkers and novel biologicals in severe asthma.   
Clin Exp Allergy 2015 Feb 1;   abstract
_______________________________________________________________

190
NFATc1 deletion in T lymphocytes inhibits the allergic trait in a murine model of asthma.   
Clin Exp Allergy 2015 Feb 1;   abstract
_______________________________________________________________

191
Management of allergy to penicillins and other beta-lactams.   
Clin Exp Allergy 2015 Feb;45(2):300-327   abstract
_______________________________________________________________

192
Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany.   
Clin Transl Allergy 2015;51   abstract
_______________________________________________________________

193
Influence of the route of exposure and the matrix on the sensitisation potency of a major cows' milk allergen.   
Clin Transl Allergy 2015;5(1):3   abstract
_______________________________________________________________

194
Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study.   
Clin Transl Allergy 2015;5(1):5   abstract
_______________________________________________________________

195
The development and implementation of a training package for dietitians on cow's milk protein allergy in infants and children based on UK RCPCH competencies for food allergies - a pilot study.   
Clin Transl Allergy 2015;5(1):4   abstract
_______________________________________________________________

196
The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice.   
Clin Transl Allergy 2015;5(1):2   abstract
_______________________________________________________________

197
Toll-Like Receptor Pathways in Autoimmune Diseases.   
Clin Rev Allergy Immunol 2015 Feb 17;   abstract
_______________________________________________________________

198
The coexistence of Sjogren's syndrome and primary biliary cirrhosis: a comprehensive review.   
Clin Rev Allergy Immunol 2015 Feb 15;   abstract
_______________________________________________________________

199
A critical review of the effects of hydroxychloroquine and chloroquine on the eye.   
Clin Rev Allergy Immunol 2015 Feb 12;   abstract
_______________________________________________________________

200
SCUBA Diving and Asthma: Clinical Recommendations and Safety.   
Clin Rev Allergy Immunol 2015 Feb 10;   abstract
_______________________________________________________________

201
CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.   
Clin Rev Allergy Immunol 2015 Feb 10;   abstract
_______________________________________________________________

202
Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).   
Clin Rev Allergy Immunol 2015 Feb 8;   abstract
_______________________________________________________________

203
Rhinovirus and asthma: a storied history of incompatibility.   
Curr Allergy Asthma Rep 2015 Feb;15(2):502   abstract
_______________________________________________________________

204
Maternal influences over offspring allergic responses.   
Curr Allergy Asthma Rep 2015 Feb;15(2):501   abstract
_______________________________________________________________

205
Natural killer cells in the development of asthma.   
Curr Allergy Asthma Rep 2015 Feb;15(2):500   abstract
_______________________________________________________________

206
Immune reconstitution inflammatory syndrome associated with biologic therapy.   
Curr Allergy Asthma Rep 2015 Feb;15(2):499   abstract
_______________________________________________________________

207
Sublingual immunotherapy in the treatment of atopic dermatitis: a systematic review using the GRADE system.   
Curr Allergy Asthma Rep 2015 Feb;15(2):498   abstract
_______________________________________________________________

208
Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?   
Curr Allergy Asthma Rep 2015 Feb;15(2):497   abstract
_______________________________________________________________

209
Challenges for allergy diagnosis in regions with complex pollen exposures.   
Curr Allergy Asthma Rep 2015 Feb;15(2):496   abstract
_______________________________________________________________

210
Molecular mechanisms of nasal epithelium in rhinitis and rhinosinusitis.   
Curr Allergy Asthma Rep 2015 Feb;15(2):495   abstract
_______________________________________________________________

211
Innate responses to pollen allergens.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):79-88   abstract
_______________________________________________________________

212
Upper airways in aspirin-exacerbated respiratory disease.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):21-26   abstract
_______________________________________________________________

213
Clinical phenotypes of asthma should link up with disease mechanisms.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):56-62   abstract
_______________________________________________________________

214
Taste receptors in asthma.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):63-69   abstract
_______________________________________________________________

215
8-Oxoguanine DNA glycosylase-1-driven DNA base excision repair: role in asthma pathogenesis.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):89-97   abstract
_______________________________________________________________

216
Adherence to asthma treatments: 'we know, we intend, we advocate'.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):49-55   abstract
_______________________________________________________________

217
The paradigm of cytokine networks in allergic airway inflammation.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):41-48   abstract
_______________________________________________________________

218
DNA methylation, bacteria and airway inflammation: latest insights.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):27-32   abstract
_______________________________________________________________

219
Risk factors for chronic rhinosinusitis.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):1-13   abstract
_______________________________________________________________

220
Gene-environment interactions in the study of asthma in the postgenomewide association studies era.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):70-78   abstract
_______________________________________________________________

221
Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation.   
Curr Opin Allergy Clin Immunol 2015 Feb;15(1):98-103   abstract
_______________________________________________________________

222
Fish-allergic patients may be able to eat fish.   
Expert Rev Clin Immunol 2015 Feb 10;1-12   abstract
_______________________________________________________________

223
Tofacitinib for the treatment of moderate-to-severe psoriasis.   
Expert Rev Clin Immunol 2015 Feb 10;1-13   abstract
_______________________________________________________________

224
Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition.   
Expert Rev Clin Immunol 2015 Feb 10;1-17   abstract
_______________________________________________________________

225
Intelligent use and clinical benefits of electronic health records in rheumatoid arthritis.   
Expert Rev Clin Immunol 2015 Feb 8;1-9   abstract
_______________________________________________________________

226
Lipopolysaccharide challenge: immunological effects and safety in humans.   
Expert Rev Clin Immunol 2015 Feb 6;1-10   abstract
_______________________________________________________________

227
Emerging biologics for the treatment of chronic rhinosinusitis.   
Expert Rev Clin Immunol 2015 Feb 5;1-13   abstract
_______________________________________________________________

228
Certolizumab pegol for the treatment of psoriatic arthritis.   
Expert Rev Clin Immunol 2015 Feb 5;1-12   abstract
_______________________________________________________________

229
Innate immunity in solid organ transplantation: an update and therapeutic opportunities.   
Expert Rev Clin Immunol 2015 Feb 3;1-13   abstract
_______________________________________________________________

230
Treatment of granulomatosis with polyangiitis (Wegener's).   
Expert Rev Clin Immunol 2015 Feb 2;1-10   abstract
_______________________________________________________________

231
Genotyping in rheumatoid arthritis: a game changer in clinical management?   
Expert Rev Clin Immunol 2015 Feb 2;1-3   abstract
_______________________________________________________________

232
Decitabine: a promising epi-immunotherapeutic agent in solid tumors.   
Expert Rev Clin Immunol 2015 Jan 12;1-13   abstract
_______________________________________________________________

233
Omalizumab for the treatment of chronic urticaria.   
Expert Rev Clin Immunol 2015 Feb;11(2):171-180   abstract
_______________________________________________________________

234
Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children.   
Expert Rev Clin Immunol 2015 Feb;11(2):289-302   abstract
_______________________________________________________________

235
Belimumab for the treatment of systemic lupus erythematosus.   
Expert Rev Clin Immunol 2015 Feb;11(2):195-204   abstract
_______________________________________________________________

236
NOS2 and CCL27: clinical implications for psoriasis and eczema diagnosis and management.   
Expert Rev Clin Immunol 2015 Feb;11(2):167-169   abstract
_______________________________________________________________

237
Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?   
Expert Rev Clin Immunol 2015 Jan;11(1):45-58   abstract
_______________________________________________________________

238
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.   
Expert Rev Clin Immunol 2015 Jan;11(1):15-31   abstract
_______________________________________________________________

239
Expert Review of Clinical Immunology 10-year anniversary issue.   
Expert Rev Clin Immunol 2015 Jan;11(1):1-3   abstract
_______________________________________________________________

240
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.   
Expert Rev Clin Immunol 2015 Jan;11(1):69-91   abstract
_______________________________________________________________

241
STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?   
Expert Rev Clin Immunol 2015 Jan;11(1):155-165   abstract
_______________________________________________________________

242
Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.   
Expert Rev Clin Immunol 2015 Feb;11(2):247-253   abstract
_______________________________________________________________

243
Primary immunodeficiencies: a decade of shifting paradigms, the current status and the emergence of cutting-edge therapies and diagnostics.   
Expert Rev Clin Immunol 2015 Jan;11(1):117-139   abstract
_______________________________________________________________

244
Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies.   
Expert Rev Clin Immunol 2015 Jan;11(1):109-116   abstract
_______________________________________________________________

245
Teriflunomide for the treatment of relapsing-remitting multiple sclerosis.   
Expert Rev Clin Immunol 2015 Feb;11(2):181-194   abstract
_______________________________________________________________

246
Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates.   
Expert Rev Clin Immunol 2015 Jan;11(1):93-108   abstract
_______________________________________________________________

247
The intelligent use and clinical benefits of electronic medical records in multiple sclerosis.   
Expert Rev Clin Immunol 2015 Feb;11(2):205-211   abstract
_______________________________________________________________

248
Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future.   
Expert Rev Clin Immunol 2015 Jan;11(1):33-44   abstract
_______________________________________________________________

249
The multifaceted aspects of refractory lupus nephritis.   
Expert Rev Clin Immunol 2015 Feb;11(2):281-288   abstract
_______________________________________________________________

250
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.   
Expert Rev Clin Immunol 2015 Feb;11(2):233-245   abstract
_______________________________________________________________

251
Dendritic cell-based vaccine research against cancer.   
Expert Rev Clin Immunol 2015 Feb;11(2):213-232   abstract
_______________________________________________________________

252
Islet transplantation for Type 1 diabetes: where are we now?   
Expert Rev Clin Immunol 2015 Jan;11(1):59-68   abstract
_______________________________________________________________

253
The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.   
Expert Rev Clin Immunol 2015 Jan;11(1):141-154   abstract
_______________________________________________________________

254
The evolution of our understanding of macrophages and translation of findings toward the clinic.   
Expert Rev Clin Immunol 2015 Jan;11(1):5-13   abstract
_______________________________________________________________

255
Sublingual allergen immunotherapy for respiratory allergies: what is new?   
Expert Rev Clin Immunol 2014 Dec;10(12):1641-1647   abstract
_______________________________________________________________

256
Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.   
Expert Rev Clin Immunol 2014 Dec;10(12):1567-1579   abstract
_______________________________________________________________

257
Domestic exposure to volatile organic compounds in relation to asthma and allergy in children and adults.   
Expert Rev Clin Immunol 2014 Dec;10(12):1611-1639   abstract
_______________________________________________________________

258
Epileptic seizures as a manifestation of cow's milk allergy: a studied relationship and description of our pediatric experience.   
Expert Rev Clin Immunol 2014 Dec;10(12):1597-1609   abstract
_______________________________________________________________

259
Immunological basis in the pathogenesis and treatment of bladder cancer.   
Expert Rev Clin Immunol 2015 Feb;11(2):265-279   abstract
_______________________________________________________________

260
Immunological effects and therapeutic role of C5a in cancer.   
Expert Rev Clin Immunol 2015 Feb;11(2):255-263   abstract
_______________________________________________________________

261
Newborn screening for SCID: where are we now?   
Expert Rev Clin Immunol 2014 Dec;10(12):1649-1657   abstract
_______________________________________________________________

262
Diagnosis and management of primary biliary cirrhosis.   
Expert Rev Clin Immunol 2014 Dec;10(12):1667-1678   abstract
_______________________________________________________________

263
Phosphatase Wip1 as a new therapeutic target for intestinal ischemia-reperfusion injury.   
Expert Rev Clin Immunol 2014 Dec;10(12):1591-1595   abstract
_______________________________________________________________

264
Novel in silico technology in combination with microarrays: a state-of-the-art technology for allergy diagnosis and management?   
Expert Rev Clin Immunol 2014 Dec;10(12):1559-1561   abstract
_______________________________________________________________

265
Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients?   
Expert Rev Clin Immunol 2014 Dec;10(12):1563-1565   abstract
_______________________________________________________________

266
Interleukin-15 in the treatment of cancer.   
Expert Rev Clin Immunol 2014 Dec;10(12):1689-1701   abstract
_______________________________________________________________

267
Cellular and molecular immunology of lung cancer: therapeutic implications.   
Expert Rev Clin Immunol 2014 Dec;10(12):1711-1730   abstract
_______________________________________________________________

268
Vitamin D and spondyloarthritis.   
Expert Rev Clin Immunol 2014 Dec;10(12):1581-1589   abstract
_______________________________________________________________

269
Inflammatory manifestations of HTLV-1 and their therapeutic options.   
Expert Rev Clin Immunol 2014 Nov;10(11):1531-1546   abstract
_______________________________________________________________

270
The importance of TSLP in allergic disease and its role as a potential therapeutic target.   
Expert Rev Clin Immunol 2014 Nov;10(11):1463-1474   abstract
_______________________________________________________________

271
Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.   
Expert Rev Clin Immunol 2014 Nov;10(11):1437-1451   abstract
_______________________________________________________________

272
Biologics in pediatric Crohn's disease: is it time to move to an earlier therapeutic approach?   
Expert Rev Clin Immunol 2014 Nov;10(11):1423-1426   abstract
_______________________________________________________________

273
Intravenous immunoglobulin as treatment for myasthenia gravis: current evidence and outcomes.   
Expert Rev Clin Immunol 2014 Dec;10(12):1659-1665   abstract
_______________________________________________________________

274
Immunobiology of IL-37: mechanism of action and clinical perspectives.   
Expert Rev Clin Immunol 2014 Dec;10(12):1703-1709   abstract
_______________________________________________________________

275
A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases.   
Expert Rev Clin Immunol 2014 Dec;10(12):1679-1688   abstract
_______________________________________________________________

276
Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options.   
Expert Rev Clin Immunol 2014 Nov;10(11):1487-1492   abstract
_______________________________________________________________

277
Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome.   
Expert Rev Clin Immunol 2014 Nov;10(11):1505-1517   abstract
_______________________________________________________________

278
Tests for evaluating non-immediate allergic drug reactions.   
Expert Rev Clin Immunol 2014 Nov;10(11):1475-1486   abstract
_______________________________________________________________

279
The clinical utility of anti-ribosomal P autoantibodies in systemic lupus erythematosus.   
Expert Rev Clin Immunol 2014 Nov;10(11):1493-1503   abstract
_______________________________________________________________

280
Canakinumab for the treatment of systemic juvenile idiopathic arthritis.   
Expert Rev Clin Immunol 2014 Nov;10(11):1427-1435   abstract
_______________________________________________________________

281
Molecular insights into the development of T cell-based immunotherapy for prostate cancer.   
Expert Rev Clin Immunol 2014 Nov;10(11):1547-1557   abstract
_______________________________________________________________

282
Methotrexate: an old new drug in autoimmune disease.   
Expert Rev Clin Immunol 2014 Nov;10(11):1519-1530   abstract
_______________________________________________________________

283
Clinical and biological markers of asthma control.   
Expert Rev Clin Immunol 2014 Nov;10(11):1453-1461   abstract
_______________________________________________________________

284
Long-term evaluation of a historical cohort of Iranian common variable immunodeficiency patients.   
Expert Rev Clin Immunol 2014 Oct;10(10):1405-1417   abstract
_______________________________________________________________

285
The immune escape in melanoma: role of the impaired dendritic cell function.   
Expert Rev Clin Immunol 2014 Oct;10(10):1395-1404   abstract
_______________________________________________________________

286
Current recommendations and emerging options for the treatment of allergic rhinitis.   
Expert Rev Clin Immunol 2014 Oct;10(10):1337-1347   abstract
_______________________________________________________________

287
Basophil activation tests: time for a reconsideration.   
Expert Rev Clin Immunol 2014 Oct;10(10):1325-1335   abstract
_______________________________________________________________

288
Lung transplant immunosuppression - time for a new approach?   
Expert Rev Clin Immunol 2014 Nov;10(11):1419-1421   abstract
_______________________________________________________________

289
Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.   
Expert Rev Clin Immunol 2014 Oct;10(10):1309-1324   abstract
_______________________________________________________________

290
Recent advances on cellular therapies and immune modulators for graft-versus-host disease.   
Expert Rev Clin Immunol 2014 Oct;10(10):1357-1374   abstract
_______________________________________________________________

291
Hizentra for the treatment of primary immunodeficiency.   
Expert Rev Clin Immunol 2014 Oct;10(10):1293-1307   abstract
_______________________________________________________________

292
Toll like receptors: a new hope on the horizon to treat multiple sclerosis.   
Expert Rev Clin Immunol 2014 Oct;10(10):1277-1279   abstract
_______________________________________________________________

293
Vitamin D supplementation: a potential booster for urticaria therapy.   
Expert Rev Clin Immunol 2014 Oct;10(10):1269-1271   abstract
_______________________________________________________________

294
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis: a review of its clinical pharmacology, efficacy and safety.   
Expert Rev Clin Immunol 2014 Oct;10(10):1281-1291   abstract
_______________________________________________________________

295
IL-18: a new player in immunotherapy for age-related macular degeneration?   
Expert Rev Clin Immunol 2014 Oct;10(10):1273-1275   abstract
_______________________________________________________________

296
Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment.   
Expert Rev Clin Immunol 2014 Oct;10(10):1349-1356   abstract
_______________________________________________________________

297
Vitamin D: a new player in kidney transplantation?   
Expert Rev Clin Immunol 2014 Oct;10(10):1375-1383   abstract
_______________________________________________________________

298
Steroid withdrawal in kidney allograft recipients.   
Expert Rev Clin Immunol 2014 Sep;10(9):1229-1239   abstract
_______________________________________________________________

299
Targeting IgE to facilitate oral immunotherapy for food allergy: a potential new role for anti-IgE therapy?   
Expert Rev Clin Immunol 2014 Sep;10(9):1125-1128   abstract
_______________________________________________________________

300
The roles of myeloid-derived suppressor cells in transplantation.   
Expert Rev Clin Immunol 2014 Oct;10(10):1385-1394   abstract
_______________________________________________________________

301
An update on leptin as immunomodulator.   
Expert Rev Clin Immunol 2014 Sep;10(9):1165-1170   abstract
_______________________________________________________________

302
Hypersensitivities to non-steroidal anti-inflammatory drugs.   
Expert Rev Clin Immunol 2014 Sep;10(9):1263-1268   abstract
_______________________________________________________________

303
A review of disease activity measures for psoriatic arthritis: what is the best approach?   
Expert Rev Clin Immunol 2014 Sep;10(9):1241-1254   abstract
_______________________________________________________________

304
Epigenetic coordination of acute systemic inflammation: potential therapeutic targets.   
Expert Rev Clin Immunol 2014 Sep;10(9):1141-1150   abstract
_______________________________________________________________

305
Immune responses in neonates.   
Expert Rev Clin Immunol 2014 Sep;10(9):1171-1184   abstract
_______________________________________________________________

306
Nasal filters: a novel approach to tackling allergic rhinitis.   
Expert Rev Clin Immunol 2014 Sep;10(9):1133-1135   abstract
_______________________________________________________________

307
The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets.   
Expert Rev Clin Immunol 2014 Sep;10(9):1151-1164   abstract
_______________________________________________________________

308
Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?   
Expert Rev Clin Immunol 2014 Sep;10(9):1213-1227   abstract
_______________________________________________________________

309
Mucosal environmental sensors in the pathogenesis of dry eye.   
Expert Rev Clin Immunol 2014 Sep;10(9):1137-1140   abstract
_______________________________________________________________

310
Potential and limitations of regulatory T-cell therapy in solid organ transplantation.   
Expert Rev Clin Immunol 2014 Sep;10(9):1197-1212   abstract
_______________________________________________________________

311
The role of immune and metabolic biomarkers for improved management of sepsis patients.   
Expert Rev Clin Immunol 2014 Sep;10(9):1255-1262   abstract
_______________________________________________________________

312
Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease?   
Expert Rev Clin Immunol 2014 Sep;10(9):1129-1131   abstract
_______________________________________________________________

313
Future clinical implications emerging from recent genome-wide expression studies in asthma.   
Expert Rev Clin Immunol 2014 Aug;10(8):985-1004   abstract
_______________________________________________________________

314
Mast cell transcriptome elucidation: what are the implications for allergic disease in the clinic and where do we go next?   
Expert Rev Clin Immunol 2014 Aug;10(8):977-980   abstract
_______________________________________________________________

315
Immunological basis of stem cell therapy in liver diseases.   
Expert Rev Clin Immunol 2014 Sep;10(9):1185-1196   abstract
_______________________________________________________________

316
The rise of biosimilars: potential benefits and drawbacks in rheumatoid arthritis.   
Expert Rev Clin Immunol 2014 Aug;10(8):981-983   abstract
_______________________________________________________________

317
The effect of antidrug antibodies on the sustainable efficacy of biologic therapies in rheumatoid arthritis: practical consequences.   
Expert Rev Clin Immunol 2014 Aug;10(8):1049-1057   abstract
_______________________________________________________________

318
Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications.   
Expert Rev Clin Immunol 2014 Aug;10(8):1005-1017   abstract
_______________________________________________________________

319
Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.   
Expert Rev Clin Immunol 2014 Aug;10(8):1107-1123   abstract
_______________________________________________________________

320
Etiology of leukocyte adhesion deficiency-associated periodontitis revisited: not a raging infection but a raging inflammatory response.   
Expert Rev Clin Immunol 2014 Aug;10(8):973-975   abstract
_______________________________________________________________

321
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.   
Expert Rev Clin Immunol 2014 Aug;10(8):1059-1067   abstract
_______________________________________________________________

322
Detection of anti-cytokine antibodies and their clinical relevance.   
Expert Rev Clin Immunol 2014 Aug;10(8):1029-1047   abstract
_______________________________________________________________

323
Evidence-based feeding strategies before and after the development of necrotizing enterocolitis.   
Expert Rev Clin Immunol 2014 Jul;10(7):875-884   abstract
_______________________________________________________________

324
Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies.   
Expert Rev Clin Immunol 2014 Aug;10(8):1069-1100   abstract
_______________________________________________________________

325
Acupuncture for allergic disease therapy--the current state of evidence.   
Expert Rev Clin Immunol 2014 Jul;10(7):831-841   abstract
_______________________________________________________________

326
Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.   
Expert Rev Clin Immunol 2014 Aug;10(8):1101-1106   abstract
_______________________________________________________________

327
Immunoregulatory activity of adenosine and its role in human cancer progression.   
Expert Rev Clin Immunol 2014 Jul;10(7):897-914   abstract
_______________________________________________________________

328
Presymptomatic autoantibodies in Sjogren's syndrome: what significance do they hold for the clinic?   
Expert Rev Clin Immunol 2014 Jul;10(7):815-817   abstract
_______________________________________________________________

329
Targeting neutrophils in sepsis.   
Expert Rev Clin Immunol 2014 Aug;10(8):1019-1028   abstract
_______________________________________________________________

330
Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.   
Expert Rev Clin Immunol 2014 Jul;10(7):927-961   abstract
_______________________________________________________________

331
Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.   
Expert Rev Clin Immunol 2014 Jul;10(7):843-854   abstract
_______________________________________________________________

332
The interplay between bacillus Calmette-Guerin and Treg cells and its role to prevent or cure inflammatory diseases.   
Expert Rev Clin Immunol 2014 Jun;10(6):741-745   abstract
_______________________________________________________________

333
Intravenous golimumab in rheumatoid arthritis.   
Expert Rev Clin Immunol 2014 Jul;10(7):823-830   abstract
_______________________________________________________________

334
Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis.   
Expert Rev Clin Immunol 2014 Jul;10(7):819-822   abstract
_______________________________________________________________

335
Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide.   
Expert Rev Clin Immunol 2014 Jun;10(6):791-799   abstract
_______________________________________________________________

336
Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target.   
Expert Rev Clin Immunol 2014 Jul;10(7):885-895   abstract
_______________________________________________________________

337
Timing and diversity of complementary food introduction for prevention of allergic diseases. How early and how much?   
Expert Rev Clin Immunol 2014 Jun;10(6):701-704   abstract
_______________________________________________________________

338
MicroRNAs and the immune response to respiratory virus infections.   
Expert Rev Clin Immunol 2014 Jul;10(7):963-971   abstract
_______________________________________________________________

339
Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies.   
Expert Rev Clin Immunol 2014 Jun;10(6):705-711   abstract
_______________________________________________________________

340
Spectrum of mast cell activation disorders.   
Expert Rev Clin Immunol 2014 Jun;10(6):729-739   abstract
_______________________________________________________________

341
The case for measuring anti-drug antibodies in people with multiple sclerosis.   
Expert Rev Clin Immunol 2014 Jun;10(6):697-699   abstract
_______________________________________________________________

342
Recommendations for the management of food allergies in a preschool/childcare setting and prevention of anaphylaxis.   
Expert Rev Clin Immunol 2014 Jul;10(7):867-874   abstract
_______________________________________________________________

343
Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.   
Expert Rev Clin Immunol 2014 Jul;10(7):915-926   abstract
_______________________________________________________________

344
The possible role of antimicrobial proteins in obesity-associated immunologic alterations.   
Expert Rev Clin Immunol 2014 Jul;10(7):855-866   abstract
_______________________________________________________________

345
Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.   
Expert Rev Clin Immunol 2014 Jun;10(6):713-727   abstract
_______________________________________________________________

346
Characterization of host immune responses in Ebola virus infections.   
Expert Rev Clin Immunol 2014 Jun;10(6):781-790   abstract
_______________________________________________________________

347
The potential of radioimmunotherapy as a new hope for HIV patients.   
Expert Rev Clin Immunol 2014 May;10(5):553-555   abstract
_______________________________________________________________

348
Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis.   
Expert Rev Clin Immunol 2014 Jun;10(6):747-762   abstract
_______________________________________________________________

349
Future considerations for dendritic cell immunotherapy against chronic viral infections.   
Expert Rev Clin Immunol 2014 Jun;10(6):801-813   abstract
_______________________________________________________________

350
The current relevance and use of prednisone in rheumatoid arthritis.   
Expert Rev Clin Immunol 2014 May;10(5):557-571   abstract
_______________________________________________________________

351
Immunotherapy: a new horizon for egg allergy?   
Expert Rev Clin Immunol 2014 May;10(5):677-686   abstract
_______________________________________________________________

352
Predictors for clinical outcome in psoriatic arthritis - what have we learned from cohort studies?   
Expert Rev Clin Immunol 2014 Jun;10(6):763-770   abstract
_______________________________________________________________

353
Breaking the mould - novel diagnostic and therapeutic strategies for invasive pulmonary aspergillosis in the immune deficient patient.   
Expert Rev Clin Immunol 2014 Jun;10(6):771-780   abstract
_______________________________________________________________

354
Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylates.   
Expert Rev Clin Immunol 2014 May;10(5):667-675   abstract
_______________________________________________________________

355
Secondary antibody deficiency.   
Expert Rev Clin Immunol 2014 May;10(5):583-591   abstract
_______________________________________________________________

356
Topical nasal lysine aspirin in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis with nasal polyposis.   
Expert Rev Clin Immunol 2014 May;10(5):657-665   abstract
_______________________________________________________________

357
Rheumatoid arthritis and the biological clock.   
Expert Rev Clin Immunol 2014 May;10(5):687-695   abstract
_______________________________________________________________

358
The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.   
Expert Rev Clin Immunol 2014 May;10(5):593-619   abstract
_______________________________________________________________

359
The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.   
Expert Rev Clin Immunol 2014 May;10(5):573-582   abstract
_______________________________________________________________

360
Paraneoplastic immune-mediated neurological effects of systemic cancers.   
Expert Rev Clin Immunol 2014 May;10(5):621-630   abstract
_______________________________________________________________

361
Classification criteria and treatment modalities in primary Sjogren's syndrome.   
Expert Rev Clin Immunol 2014 Apr;10(4):543-551   abstract
_______________________________________________________________

362
Macrophages: important players in primary Sjogren's syndrome?   
Expert Rev Clin Immunol 2014 Apr;10(4):513-520   abstract
_______________________________________________________________

363
Genetic, genomic and epigenetic studies as tools for elucidating disease pathogenesis in primary Sjogren's syndrome.   
Expert Rev Clin Immunol 2014 Apr;10(4):437-444   abstract
_______________________________________________________________

364
Immunization with vaccines and Sjogren's syndrome.   
Expert Rev Clin Immunol 2014 Apr;10(4):429-435   abstract
_______________________________________________________________

365
Towards inhibition of morbidity and mortality in Sjogren's syndrome: opportunities and challenges.   
Expert Rev Clin Immunol 2014 Apr;10(4):421-423   abstract
_______________________________________________________________

366
Fungus-associated asthma: overcoming challenges in diagnosis and treatment.   
Expert Rev Clin Immunol 2014 May;10(5):647-656   abstract
_______________________________________________________________

367
Tuberculosis-immune reconstitution inflammatory syndrome in HIV: from pathogenesis to prediction.   
Expert Rev Clin Immunol 2014 May;10(5):631-645   abstract
_______________________________________________________________

368
What causes dryness in Sjogren's syndrome patients and how can it be targeted?   
Expert Rev Clin Immunol 2014 Apr;10(4):425-427   abstract
_______________________________________________________________

369
B-cell hyperactivity in primary Sjogren's syndrome.   
Expert Rev Clin Immunol 2014 Apr;10(4):483-499   abstract
_______________________________________________________________

370
EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjogren's syndrome.   
Expert Rev Clin Immunol 2014 Apr;10(4):445-455   abstract
_______________________________________________________________

371
Update and insights into treatment options for chronic spontaneous urticaria.   
Expert Rev Clin Immunol 2014 Mar;10(3):397-403   abstract
_______________________________________________________________

372
A new intravenous immunoglobulin (BIVIGAM(R)) for primary humoral immunodeficiency.   
Expert Rev Clin Immunol 2014 Mar;10(3):325-337   abstract
_______________________________________________________________

373
The value of animal models to study immunopathology of primary human Sjogren's syndrome symptoms.   
Expert Rev Clin Immunol 2014 Apr;10(4):469-481   abstract
_______________________________________________________________

374
Inflammatory bowel disease and demyelination: more than just a coincidence?   
Expert Rev Clin Immunol 2014 Mar;10(3):363-373   abstract
_______________________________________________________________

375
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjogren's syndrome.   
Expert Rev Clin Immunol 2014 Apr;10(4):533-541   abstract
_______________________________________________________________

376
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward.   
Expert Rev Clin Immunol 2014 Mar;10(3):405-419   abstract
_______________________________________________________________

377
Intravenous immunoglobulin in systemic capillary leak syndrome: a case report and review of literature.   
Expert Rev Clin Immunol 2014 Mar;10(3):349-352   abstract
_______________________________________________________________

378
In vitro diagnosis of Hymenoptera venom allergy and further development of component resolved diagnostics.   
Expert Rev Clin Immunol 2014 Mar;10(3):375-384   abstract
_______________________________________________________________

379
The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance.   
Expert Rev Clin Immunol 2014 Mar;10(3):353-362   abstract
_______________________________________________________________

380
Should we encourage allergen immunotherapy during pregnancy?   
Expert Rev Clin Immunol 2014 Mar;10(3):317-319   abstract
_______________________________________________________________

381
Canakinumab for gout: a specific, patient-profiled indication.   
Expert Rev Clin Immunol 2014 Mar;10(3):339-347   abstract
_______________________________________________________________

382
Predicting progression to lymphoma in Sjogren's syndrome patients.   
Expert Rev Clin Immunol 2014 Apr;10(4):501-512   abstract
_______________________________________________________________

383
The practical role of serum allergen-specific IgE as potential biomarker for predicting responder to allergen immunotherapy.   
Expert Rev Clin Immunol 2014 Mar;10(3):321-324   abstract
_______________________________________________________________

384
Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjogren's syndrome.   
Expert Rev Clin Immunol 2014 Apr;10(4):521-531   abstract
_______________________________________________________________

385
Type I IFN signature in primary Sjogren's syndrome patients.   
Expert Rev Clin Immunol 2014 Apr;10(4):457-467   abstract
_______________________________________________________________

386
Molecular diagnosis of primary immunodeficiency diseases in a developing country: Iran as an example.   
Expert Rev Clin Immunol 2014 Mar;10(3):385-396   abstract
_______________________________________________________________

387
Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk.   
Expert Rev Clin Immunol 2014 Feb;10(2):307-315   abstract
_______________________________________________________________

388
Diagnosis of cow's milk allergy in children: determining the gold standard?   
Expert Rev Clin Immunol 2014 Feb;10(2):257-267   abstract
_______________________________________________________________

389
Translational research and efficacy of biologics in Crohn's disease: a cautionary tale.   
Expert Rev Clin Immunol 2014 Feb;10(2):219-229   abstract
_______________________________________________________________

390
Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy.   
Expert Rev Clin Immunol 2014 Feb;10(2):207-217   abstract
_______________________________________________________________

391
Ustekinumab for the treatment of psoriatic arthritis.   
Expert Rev Clin Immunol 2014 Feb;10(2):189-202   abstract
_______________________________________________________________

392
New diagnostic criteria for CVID.   
Expert Rev Clin Immunol 2014 Feb;10(2):183-186   abstract
_______________________________________________________________

393
Steroids vs immunotherapy for allergic rhinitis - out with the old, in with the new.   
Expert Rev Clin Immunol 2014 Feb;10(2):171-173   abstract
_______________________________________________________________

394
Overlapping gene expression profiles indicative of antigen processing and the interferon pathway characterize inflammatory fibrotic skin diseases.   
Expert Rev Clin Immunol 2014 Feb;10(2):231-241   abstract
_______________________________________________________________

395
Comment on 'Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures'.   
Expert Rev Clin Immunol 2014 Feb;10(2):187-188   abstract
_______________________________________________________________

396
The pros and the cons of mTOR inhibitors in kidney transplantation.   
Expert Rev Clin Immunol 2014 Feb;10(2):295-305   abstract
_______________________________________________________________

397
Psoriasis and lasting implications.   
Expert Rev Clin Immunol 2014 Feb;10(2):175-177   abstract
_______________________________________________________________

398
Treating moderate to severe psoriasis - best use of biologics.   
Expert Rev Clin Immunol 2014 Feb;10(2):269-279   abstract
_______________________________________________________________

399
Measuring the perception of symptom, drug use and allergen immunotherapy efficacy using the Visual Analogue Scale.   
Expert Rev Clin Immunol 2014 Feb;10(2):179-182   abstract
_______________________________________________________________

400
Advances on regulatory T cells from the 15th International Congress of Immunology.   
Expert Rev Clin Immunol 2014 Feb;10(2):203-205   abstract
_______________________________________________________________

401
Cryotherapy in inflammatory rheumatic diseases: a systematic review.   
Expert Rev Clin Immunol 2014 Feb;10(2):281-294   abstract
_______________________________________________________________

402
Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?   
Expert Rev Clin Immunol 2014 Jan;10(1):1-5   abstract
_______________________________________________________________

403
Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases.   
Expert Rev Clin Immunol 2014 Feb;10(2):243-256   abstract
_______________________________________________________________

404
Paradoxical effects of anti-TNF-alpha agents in inflammatory diseases.   
Expert Rev Clin Immunol 2014 Jan;10(1):159-169   abstract
_______________________________________________________________

405
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.   
Expert Rev Clin Immunol 2014 Jan;10(1):41-62   abstract
_______________________________________________________________

406
Estrogen's effects in chronic autoimmune/inflammatory diseases and progression to cancer.   
Expert Rev Clin Immunol 2014 Jan;10(1):31-39   abstract
_______________________________________________________________

407
The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy.   
Expert Rev Clin Immunol 2014 Jan;10(1):19-30   abstract
_______________________________________________________________

408
The intelligent use of systemic glucocorticoids in rheumatoid arthritis.   
Expert Rev Clin Immunol 2014 Jan;10(1):143-157   abstract
_______________________________________________________________

409
Understanding the role of B cells in atherosclerosis: potential clinical implications.   
Expert Rev Clin Immunol 2014 Jan;10(1):77-89   abstract
_______________________________________________________________

410
Stem cell transplantation in the context of HIV--how can we cure HIV infection?   
Expert Rev Clin Immunol 2014 Jan;10(1):107-116   abstract
_______________________________________________________________

411
Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again.   
Expert Rev Clin Immunol 2014 Jan;10(1):91-105   abstract
_______________________________________________________________

412
Immunomodulation of malignant melanoma by contact sensitizing agents.   
Expert Rev Clin Immunol 2014 Jan;10(1):63-76   abstract
_______________________________________________________________

413
Anakinra for cryopyrin-associated periodic syndrome.   
Expert Rev Clin Immunol 2014 Jan;10(1):7-18   abstract
_______________________________________________________________

414
Dietary therapies for eosinophilic esophagitis.   
Expert Rev Clin Immunol 2014 Jan;10(1):133-142   abstract
_______________________________________________________________

415
Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.   
Expert Rev Clin Immunol 2014 Jan;10(1):117-132   abstract
_______________________________________________________________

416
Optimizing the use of regulatory T cells in allotransplantation: recent advances and future perspectives.   
Expert Rev Clin Immunol 2013 Dec;9(12):1303-1314   abstract
_______________________________________________________________

417
Celiac disease and endocrine autoimmune disorders in children: an update.   
Expert Rev Clin Immunol 2013 Dec;9(12):1289-1301   abstract
_______________________________________________________________

418
Prediction of hypersensitivity to antibiotics: what factors need to be considered?   
Expert Rev Clin Immunol 2013 Dec;9(12):1279-1288   abstract
_______________________________________________________________

419
Prevention of asthma: where are we in the 21st century?   
Expert Rev Clin Immunol 2013 Dec;9(12):1267-1278   abstract
_______________________________________________________________

420
The impact of breastfeeding on lung development and function: a systematic review.   
Expert Rev Clin Immunol 2013 Dec;9(12):1253-1265   abstract
_______________________________________________________________

421
Toll-like receptor signaling in neonatal sepsis and inflammation: a matter of orchestration and conditioning.   
Expert Rev Clin Immunol 2013 Dec;9(12):1239-1252   abstract
_______________________________________________________________

422
Advances in our understanding of the pathogenesis of Henoch-Schonlein purpura and the implications for improving its diagnosis.   
Expert Rev Clin Immunol 2013 Dec;9(12):1223-1238   abstract
_______________________________________________________________

423
Agammaglobulinemia: causative mutations and their implications for novel therapies.   
Expert Rev Clin Immunol 2013 Dec;9(12):1205-1221   abstract
_______________________________________________________________

424
Accelerated telomere shortening in rheumatic diseases: cause or consequence?   
Expert Rev Clin Immunol 2013 Dec;9(12):1193-1204   abstract
_______________________________________________________________

425
The case for measuring antibodies to specific citrullinated antigens.   
Expert Rev Clin Immunol 2013 Dec;9(12):1185-1192   abstract
_______________________________________________________________

426
Predictors of progression to Type 1 diabetes: preparing for immune interventions in the preclinical disease phase.   
Expert Rev Clin Immunol 2013 Dec;9(12):1173-1183   abstract
_______________________________________________________________

427
Certolizumab pegol in axial spondyloarthritis.   
Expert Rev Clin Immunol 2013 Dec;9(12):1161-1172   abstract
_______________________________________________________________

428
Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?   
Expert Rev Clin Immunol 2013 Dec;9(12):1155-1157   abstract
_______________________________________________________________

429
The clinical potential for koff-rate measurement in adoptive immunotherapy.   
Expert Rev Clin Immunol 2013 Dec;9(12):1151-1153   abstract
_______________________________________________________________

430
Immunodiscordant responses to HAART--mechanisms and consequences.   
Expert Rev Clin Immunol 2013 Nov;9(11):1135-1149   abstract
_______________________________________________________________

431
Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.   
Expert Rev Clin Immunol 2013 Nov;9(11):1113-1124   abstract
_______________________________________________________________

432
Association of cytokine/costimulatory molecule polymorphism and allograft rejection: a comparative review.   
Expert Rev Clin Immunol 2013 Nov;9(11):1099-1112   abstract
_______________________________________________________________

433
Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.   
Expert Rev Clin Immunol 2013 Nov;9(11):1077-1090   abstract
_______________________________________________________________

434
The interaction between autoimmune diseases and fibromyalgia: risk, disease course and management.   
Expert Rev Clin Immunol 2013 Nov;9(11):1069-1076   abstract
_______________________________________________________________

435
Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease.   
Expert Rev Clin Immunol 2013 Nov;9(11):1055-1068   abstract
_______________________________________________________________

436
Immunology of stiff person syndrome and other GAD-associated neurological disorders.   
Expert Rev Clin Immunol 2013 Nov;9(11):1043-1053   abstract
_______________________________________________________________

437
A case for antibiotic perturbation of the microbiota leading to allergy development.   
Expert Rev Clin Immunol 2013 Nov;9(11):1019-1030   abstract
_______________________________________________________________

438
A possible turning point in the hematopoietic stem cell gene therapy for primary immunodeficiency diseases? Lentiviral vectors could take the place of retroviral vectors.   
Expert Rev Clin Immunol 2013 Nov;9(11):1015-1018   abstract
_______________________________________________________________

439
Is urine mRNA analysis a useful tool in the detection of acute rejection?   
Expert Rev Clin Immunol 2013 Nov;9(11):1011-1013   abstract
_______________________________________________________________

440
Looking for the best target for biologic treatment of spondyloarthritis.   
Expert Rev Clin Immunol 2013 Nov;9(11):1005-1007   abstract
_______________________________________________________________

441
Targeting proinsulin-reactive CD8+ T cells: a new direction for type 1 diabetes treatment.   
Expert Rev Clin Immunol 2013 Nov;9(11):1001-1003   abstract
_______________________________________________________________

442
A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis.   
Expert Rev Clin Immunol 2013 Nov;9(11):1091-1097   abstract
_______________________________________________________________

443
The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.   
Expert Rev Clin Immunol 2013 Nov;9(11):1031-1041   abstract
_______________________________________________________________

444
Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives.   
Expert Rev Clin Immunol 2013 Nov;9(11):1125-1133   abstract
_______________________________________________________________

445
Advances in hematopoietic stem cell transplantation for primary immunodeficiency.   
Expert Rev Clin Immunol 2013 Oct;9(10):991-999   abstract
_______________________________________________________________

446
Cardiovascular comorbidities in antiphospholipid syndrome.   
Expert Rev Clin Immunol 2013 Oct;9(10):987-990   abstract
_______________________________________________________________

447
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?   
Expert Rev Clin Immunol 2013 Oct;9(10):979-986   abstract
_______________________________________________________________

448
Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures.   
Expert Rev Clin Immunol 2013 Oct;9(10):959-977   abstract
_______________________________________________________________

449
Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response.   
Expert Rev Clin Immunol 2013 Oct;9(10):949-958   abstract
_______________________________________________________________

450
Characterizing wheeze phenotypes to identify endotypes of childhood asthma, and the implications for future management.   
Expert Rev Clin Immunol 2013 Oct;9(10):921-936   abstract
_______________________________________________________________

451
Clinical view on the importance of dendritic cells in asthma.   
Expert Rev Clin Immunol 2013 Oct;9(10):899-919   abstract
_______________________________________________________________

452
Recent advances in immunotherapy: the active treatment of food allergy on the horizon.   
Expert Rev Clin Immunol 2013 Oct;9(10):891-893   abstract
_______________________________________________________________

453
Two demyelinating diseases in the brain of a single patient, PML and MS: how to minimize 'one' while treating the 'other'.   
Expert Rev Clin Immunol 2013 Oct;9(10):887-890   abstract
_______________________________________________________________

454
Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?   
Expert Rev Clin Immunol 2013 Oct;9(10):937-947   abstract
_______________________________________________________________

455
Sisyphus, the Giffen's paradox and the Holy Grail: time for organ transplantation to transition toward a regenerative medicine-focused type of research.   
Expert Rev Clin Immunol 2013 Oct;9(10):883-885   abstract
_______________________________________________________________

456
Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?   
Expert Rev Clin Immunol 2013 Sep;9(9):871-882   abstract
_______________________________________________________________

457
Prevention of anaphylaxis in healthcare settings.   
Expert Rev Clin Immunol 2013 Sep;9(9):855-869   abstract
_______________________________________________________________

458
A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis and challenges facing the field.   
Expert Rev Clin Immunol 2013 Sep;9(9):845-854   abstract
_______________________________________________________________

459
Impact of donor-specific antibodies in reconstructive transplantation.   
Expert Rev Clin Immunol 2013 Sep;9(9):835-844   abstract
_______________________________________________________________

460
Immune response in chronic obstructive pulmonary disease.   
Expert Rev Clin Immunol 2013 Sep;9(9):821-833   abstract
_______________________________________________________________

461
Vitamin D in pregnancy and early life: the right target for prevention of allergic disease?   
Expert Rev Clin Immunol 2013 Sep;9(9):817-820   abstract
_______________________________________________________________

462
Highlights on the EAACI-WAO Congress 2013.   
Expert Rev Clin Immunol 2013 Sep;9(9):813-815   abstract
_______________________________________________________________

463
MP29-02 for the treatment of seasonal allergic rhinitis: a review of clinical pharmacology, efficacy and safety.   
Expert Rev Clin Immunol 2013 Sep;9(9):803-811   abstract
_______________________________________________________________

464
Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barre syndrome?   
Expert Rev Clin Immunol 2013 Sep;9(9):795-797   abstract
_______________________________________________________________

465
Parents' perceptions of the HPV vaccine: a key target for improving immunization rates.   
Expert Rev Clin Immunol 2013 Sep;9(9):791-793   abstract
_______________________________________________________________

466
Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature.   
Expert Rev Clin Immunol 2013 Aug;9(8):781-789   abstract
_______________________________________________________________

467
Assessing immunologic risk factors in transplantation.   
Expert Rev Clin Immunol 2013 Aug;9(8):773-779   abstract
_______________________________________________________________

468
B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress.   
Expert Rev Clin Immunol 2013 Aug;9(8):761-772   abstract
_______________________________________________________________

469
Role of vitamin D in the pathogenesis and treatment of atopic dermatitis.   
Expert Rev Clin Immunol 2013 Aug;9(8):751-760   abstract
_______________________________________________________________

470
The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus.   
Expert Rev Clin Immunol 2013 Aug;9(8):739-749   abstract
_______________________________________________________________

471
Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease.   
Expert Rev Clin Immunol 2013 Aug;9(8):727-738   abstract
_______________________________________________________________

472
Nutrigenetics, nutrigenomics and inflammatory bowel diseases.   
Expert Rev Clin Immunol 2013 Aug;9(8):717-726   abstract
_______________________________________________________________

473
Food protein-induced enterocolitis syndrome, from practice to theory.   
Expert Rev Clin Immunol 2013 Aug;9(8):707-715   abstract
_______________________________________________________________

474
Can vitamin D intake during pregnancy affect the risk of allergy in children?   
Expert Rev Clin Immunol 2013 Aug;9(8):699-701   abstract
_______________________________________________________________

475
Does the level of bacterial exposure in early life impact the risk of Type 1 diabetes?   
Expert Rev Clin Immunol 2013 Aug;9(8):695-697   abstract
_______________________________________________________________

476
Current recommendations for multiple sclerosis treatment in pregnancy and puerperium.   
Expert Rev Clin Immunol 2013 Jul;9(7):683-691   abstract
_______________________________________________________________

477
Rationale and early clinical data on IL-17 blockade in psoriasis.   
Expert Rev Clin Immunol 2013 Jul;9(7):677-682   abstract
_______________________________________________________________

478
Trichinella spiralis immunomodulation: an interactive multifactorial process.   
Expert Rev Clin Immunol 2013 Jul;9(7):669-675   abstract
_______________________________________________________________

479
The current standing of diagnosis of antiphospholipid syndrome associated with systemic lupus erythematosus.   
Expert Rev Clin Immunol 2013 Jul;9(7):659-668   abstract
_______________________________________________________________

480
Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.   
Expert Rev Clin Immunol 2013 Jul;9(7):649-657   abstract
_______________________________________________________________

481
Current understanding of the pathogenesis of granulomatosis with polyangiitis (Wegener's).   
Expert Rev Clin Immunol 2013 Jul;9(7):641-648   abstract
_______________________________________________________________

482
Infectious and noninfectious triggers in Guillain-Barre syndrome.   
Expert Rev Clin Immunol 2013 Jul;9(7):627-639   abstract
_______________________________________________________________

483
Breastfeeding and tacrolimus: is it a reasonable approach?   
Expert Rev Clin Immunol 2013 Jul;9(7):623-626   abstract
_______________________________________________________________

484
Update on the use of abatacept for the treatment of rheumatoid arthritis.   
Expert Rev Clin Immunol 2013 Jul;9(7):599-621   abstract
_______________________________________________________________

485
Vitamin D in rheumatoid arthritis.   
Expert Rev Clin Immunol 2013 Jul;9(7):591-593   abstract
_______________________________________________________________

486
New research in HIV immunity points way for vaccine.   
Expert Rev Clin Immunol 2013 May;9(5):403   abstract
_______________________________________________________________

487
Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study.   
Expert Rev Clin Immunol 2013 May;9(5):402   abstract
_______________________________________________________________

488
Improving patient tolerability in immunoglobulin treatment: focus on stabilizer effects.   
Expert Rev Clin Immunol 2013 Jun;9(6):577-587   abstract
_______________________________________________________________

489
A review on guidelines for management and treatment of common variable immunodeficiency.   
Expert Rev Clin Immunol 2013 Jun;9(6):561-574   abstract
_______________________________________________________________

490
Recent advances in the diagnosis and therapy of peanut allergy.   
Expert Rev Clin Immunol 2013 Jun;9(6):551-560   abstract
_______________________________________________________________

491
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.   
Expert Rev Clin Immunol 2013 Jun;9(6):535-549   abstract
_______________________________________________________________

492
1,25-dihydroxyvitamin D in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.   
Expert Rev Clin Immunol 2013 Jun;9(6):517-533   abstract
_______________________________________________________________

493
Spondyloarthritis and smoking: towards a new insight into the disease.   
Expert Rev Clin Immunol 2013 Jun;9(6):511-516   abstract
_______________________________________________________________

494
Beyond anti-TNF-alpha agents in psoriatic arthritis.   
Expert Rev Clin Immunol 2013 Jun;9(6):507-509   abstract
_______________________________________________________________

495
Rescue therapy: ciclosporin or infliximab?   
Expert Rev Clin Immunol 2013 Jun;9(6):503-505   abstract
_______________________________________________________________

496
Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment.   
Expert Rev Clin Immunol 2013 Jun;9(6):495-497   abstract
_______________________________________________________________

497
Lipoxin A4: a new direction in asthma therapy?   
Expert Rev Clin Immunol 2013 Jun;9(6):491-493   abstract
_______________________________________________________________

498
Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.   
Expert Rev Clin Immunol 2013 May;9(5):477-488   abstract
_______________________________________________________________

499
A comparison of immunotherapy delivery methods for allergen immunotherapy.   
Expert Rev Clin Immunol 2013 May;9(5):465-474   abstract
_______________________________________________________________

500
Vitamin D and systemic lupus erythematosus: an update.   
Expert Rev Clin Immunol 2013 May;9(5):453-463   abstract
_______________________________________________________________

501
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS.   
Expert Rev Clin Immunol 2013 May;9(5):441-452   abstract
_______________________________________________________________

502
New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.   
Expert Rev Clin Immunol 2013 May;9(5):423-440   abstract
_______________________________________________________________

503
Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.   
Expert Rev Clin Immunol 2013 May;9(5):409-422   abstract
_______________________________________________________________

504
Targeting IL-15 in large granular lymphocyte leukemia.   
Expert Rev Clin Immunol 2013 May;9(5):405-408   abstract
_______________________________________________________________

505
Study suggests link between high vitamin D levels at pregnancy and pediatric allergy.   
Expert Rev Clin Immunol 2013 May;9(5):401   abstract
_______________________________________________________________

506
Vitamins and systemic lupus erythematosus: to D or not to D.   
Expert Rev Clin Immunol 2013 May;9(5):397-399   abstract
_______________________________________________________________

507
Immune monitoring of children with respiratory syncytial virus infection.   
Expert Rev Clin Immunol 2013 May;9(5):393-395   abstract
_______________________________________________________________

508
Sublingual immunotherapy in preschool children: an update.   
Expert Rev Clin Immunol 2013 Apr;9(4):385-390   abstract
_______________________________________________________________

509
Exclusive enteral nutrition and induction of remission of active Crohn's disease in children.   
Expert Rev Clin Immunol 2013 Apr;9(4):375-383   abstract
_______________________________________________________________

510
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum.   
Expert Rev Clin Immunol 2013 Apr;9(4):361-373   abstract
_______________________________________________________________

511
Tuberculosis in the course of sarcoidosis treatment: is genotyping necessary for personalized therapy?   
Expert Rev Clin Immunol 2013 Apr;9(4):349-360   abstract
_______________________________________________________________

512
Importance of reverse signaling of the TNF superfamily in immune regulation.   
Expert Rev Clin Immunol 2013 Apr;9(4):335-348   abstract
_______________________________________________________________

513
The genetic basis of resistance to HIV infection and disease progression.   
Expert Rev Clin Immunol 2013 Apr;9(4):319-334   abstract
_______________________________________________________________

514
Systems level immune response analysis and personalized medicine.   
Expert Rev Clin Immunol 2013 Apr;9(4):307-317   abstract
_______________________________________________________________

515
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease--an update.   
Expert Rev Clin Immunol 2013 Apr;9(4):301-306   abstract
_______________________________________________________________

516
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.   
Expert Rev Clin Immunol 2013 Apr;9(4):297-299   abstract
_______________________________________________________________

517
Spondyloarthropathy: frontier for molecular targets?   
Expert Rev Clin Immunol 2013 Apr;9(4):289-291   abstract
_______________________________________________________________

518
Emerging concepts of dietary therapy for pediatric and adult eosinophilic esophagitis.   
Expert Rev Clin Immunol 2013 Apr;9(4):285-287   abstract
_______________________________________________________________

519
Leptospirosis: current situation and trends of specific laboratory tests.   
Expert Rev Clin Immunol 2013 Mar;9(3):263-280   abstract
_______________________________________________________________

520
Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults.   
Expert Rev Clin Immunol 2013 Mar;9(3):251-261   abstract
_______________________________________________________________

521
Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy.   
Expert Rev Clin Immunol 2013 Mar;9(3):235-249   abstract
_______________________________________________________________

522
Allergy to ortho-phthalaldehyde in the healthcare setting: advice for clinicians.   
Expert Rev Clin Immunol 2013 Mar;9(3):227-234   abstract
_______________________________________________________________

523
Immunopathogenesis of allergic disorders: current concepts.   
Expert Rev Clin Immunol 2013 Mar;9(3):211-226   abstract
_______________________________________________________________

524
Fueling autoimmunity: type I interferon in autoimmune diseases.   
Expert Rev Clin Immunol 2013 Mar;9(3):201-210   abstract
_______________________________________________________________

525
Infections during treatment with biological agents and possible treatment in clinical practice.   
Expert Rev Clin Immunol 2013 Mar;9(3):193-195   abstract
_______________________________________________________________

526
The benefits and risks of alemtuzumab in multiple sclerosis.   
Expert Rev Clin Immunol 2013 Mar;9(3):189-191   abstract
_______________________________________________________________

527
Evolution and future prospects of adipose-derived immunomodulatory cell therapeutics.   
Expert Rev Clin Immunol 2013 Feb;9(2):175-184   abstract
_______________________________________________________________

528
Management of inflammatory bowel disease in pregnancy.   
Expert Rev Clin Immunol 2013 Feb;9(2):161-173   abstract
_______________________________________________________________

529
Pulmonary manifestations of chronic granulomatous disease.   
Expert Rev Clin Immunol 2013 Feb;9(2):153-160   abstract
_______________________________________________________________

530
Determining EBV load: current best practice and future requirements.   
Expert Rev Clin Immunol 2013 Feb;9(2):139-151   abstract
_______________________________________________________________

531
Mast cells: multitalented facilitators of protection against bacterial pathogens.   
Expert Rev Clin Immunol 2013 Feb;9(2):129-138   abstract
_______________________________________________________________

532
Loss of response to biologics versus increased risk of lymphoma in children with inflammatory bowel disease: the clinician's conundrum.   
Expert Rev Clin Immunol 2013 Feb;9(2):117-127   abstract
_______________________________________________________________

533
Vitamin A: yet another player in multiple sclerosis pathogenesis?   
Expert Rev Clin Immunol 2013 Feb;9(2):113-115   abstract
_______________________________________________________________

534
Sarcoidosis-associated fatigue: an often forgotten symptom--author reply.   
Expert Rev Clin Immunol 2013 Feb;9(2):111   abstract
_______________________________________________________________

535
Sarcoidosis-associated fatigue: an often forgotten symptom.   
Expert Rev Clin Immunol 2013 Feb;9(2):109-110   abstract
_______________________________________________________________

536
Psoriasis and susceptibility to other autoimmune diseases: an outline for the clinician.   
Expert Rev Clin Immunol 2013 Feb;9(2):99-101   abstract
_______________________________________________________________

537
EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop?   
Expert Rev Clin Immunol 2013 Feb;9(2):95-97   abstract
_______________________________________________________________

Previous Issues of Allergy Advisor Digest
January 2010   February 2010   March 2010   April 2010   May 2010   June 2010   July 2010   August 2010   September 2010   October 2010   November 2010   December 2010   January 2011   February 2011   March 2011   April 2011   May 2011   June 2011   July 2011   August 2011   September 2011   October 2011   November 2011   December 2011   January 2012   February 2012   March 2012   April 2012   May 2012   June 2012   July 2012   August 2012   September 2012   October 2012   November 2012   December 2012   January 2013   February 2013   March 2013   April 2013   May 2013   June 2013   July 2013   August 2013   September 2013   October 2013   November 2013   December 2013   January 2014   February 2014   March 2014   April 2014   May 2014   June 2014   July 2014   August 2014   September 2014   October 2014   November 2014   December 2014   January 2015   February 2015  


To subscribe to future Digest installments , subscribe here, and we will notify you when the new Digest is published.

Close


Allergy and Intolerance Information